1. Home
  2. AEIS vs CORT Comparison

AEIS vs CORT Comparison

Compare AEIS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advanced Energy Industries Inc.

AEIS

Advanced Energy Industries Inc.

N/A

Current Price

$224.53

Market Cap

8.9B

Sector

Technology

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$80.56

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEIS
CORT
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
9.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
AEIS
CORT
Price
$224.53
$80.56
Analyst Decision
Strong Buy
Buy
Analyst Count
12
5
Target Price
★ $415.00
$141.00
AVG Volume (30 Days)
573.7K
★ 869.8K
Earning Date
11-02-2026
11-03-2026
Dividend Yield
★ 0.18%
N/A
EPS Growth
★ 168.53
N/A
EPS
★ 2.86
0.09
Revenue
$453,095,000.00
★ $761,407,000.00
Revenue This Year
$34.79
$50.53
Revenue Next Year
$24.79
$46.23
P/E Ratio
★ $77.66
$903.72
Revenue Growth
★ 38.39
12.79
52 Week Low
$187.71
$28.66
52 Week High
$397.44
$126.38

Technical Indicators

Market Signals
Indicator
AEIS
CORT
Relative Strength Index (RSI) 39.09 23.20
Support Level $210.50 $77.38
Resistance Level $350.63 $122.93
Average True Range (ATR) 11.99 5.62
MACD -1.09 -3.25
Stochastic Oscillator 28.11 3.22

Price Performance

Historical Comparison
AEIS
CORT

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: